Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000228179 | SCV000287612 | likely benign | Colorectal cancer, susceptibility to, 10 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000564952 | SCV000671049 | likely benign | Hereditary cancer-predisposing syndrome | 2015-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001722234 | SCV000715619 | likely benign | not provided | 2020-11-24 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000601019 | SCV001470058 | benign | not specified | 2020-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001722234 | SCV004140569 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | POLD1: BP4, BP7 |
Prevention |
RCV003929958 | SCV004740013 | likely benign | POLD1-related condition | 2019-09-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |